Current antioxidant molecular therapies for oxidative stress-related ailments

Martha E Ramos-Márquez1, Fernando Siller-López

  • 1Instituto de Enfermedades Crónico Degeneratives, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara. Guadalajara, Jal., Mexico.

Current Gene Therapy
|August 12, 2008
PubMed

Insights

Oxidative stress causes cell damage, but antioxidants can help. Gene therapy shows promise for delivering antioxidants directly to damaged cells, offering a new treatment for related disorders.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Oxidative cell damage occurs naturally in aerobic environments but can be repaired by cellular antioxidants.
  • An imbalance favoring oxidants over antioxidants, due to various insults, can lead to pathological conditions.
  • Compounds with antioxidant properties are widely used to manage health, but achieving effective levels at target cells remains a challenge.

Purpose of the Study:

  • To review current molecular pharmacological strategies for combating oxidative stress.
  • To emphasize gene transfer protocols as a therapeutic approach for oxidative stress-related disorders.

Main Methods:

  • Literature review of antioxidant molecular pharmacology.
  • Focus on gene transfer and gene delivery systems for antioxidant gene expression.
  • Analysis of strategies for treating oxidative stress-related disorders.

Main Results:

  • Pharmacological, dietary, and complementary therapies are explored for counteracting oxidation.
  • Gene delivery of recombinant antioxidant genes to target cells shows significant therapeutic potential.
  • Current research highlights the efficacy of gene transfer in addressing oxidative stress.

Conclusions:

  • Restoring the oxidant/antioxidant balance is crucial for preventing and treating oxidative stress-related diseases.
  • Gene therapy offers a promising avenue for targeted antioxidant delivery, overcoming limitations of conventional methods.
  • Further research into gene transfer protocols is essential for advancing treatments for oxidative stress disorders.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...